Clinical Trial Update: The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring

View source ↗

Summary

This clinical trial update discusses the potential value of circulating tumor cells for monitoring postoperative recurrence in patients with non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: GenoSaber | Conditions: Non-small-cell Lung Carcinoma | Status: UNKNOWN